Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, Trustmark Corporation (TRMK) has a Wall Street consensus price target of $45.50, based on estimates from 9 covering analysts. With the stock currently trading at $44.76, this represents a potential upside of +1.7%. The company has a market capitalization of $2.64B.
Analyst price targets range from a low of $45.50 to a high of $45.50, representing a 0% spread in expectations. The median target of $45.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, TRMK trades at a trailing P/E of 12.1x and forward P/E of 11.5x. The forward PEG ratio of 1.42 indicates reasonable valuation for growth. Analysts expect EPS to grow +4.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $85.30, with bear and bull scenarios of $24.08 and $188.74 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonQuick answers to the most common questions about buying TRMK stock.
The consensus price target for TRMK is $45.5, close to the current price of $44.76 (1.7% implied move). Based on 9 analyst estimates, the stock appears fairly valued near current levels.
TRMK has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $45.5 implies 1.7% upside from current levels.
With a forward P/E of 11.4622x, TRMK trades at a relatively low valuation. The consensus target of $45.5 implies 1.7% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $45.5 for TRMK, while the most conservative target is $45.5. The consensus of $45.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $189 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
TRMK is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 7 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TRMK stock forecast based on 9 Wall Street analysts shows a consensus price target of $45.5, with estimates ranging from $45.5 (bear case) to $45.5 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $85, with bear/bull scenarios of $24/$189.
Our quantitative valuation model calculates TRMK's fair value at $85 (base case), with a bear case of $24 and bull case of $189. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
TRMK trades at a forward P/E ratio of 11.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
TRMK appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $45.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TRMK analyst price targets range from $45.5 to $45.5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $45.5 consensus represents the middle ground. Our model's $24-$189 range provides an independent fundamental perspective.